(CLMT) Calumet Specialty Products - Overview
Stock: Solvents, Waxes, Lubricants, Renewable Diesel, Asphalt
| Risk 5d forecast | |
|---|---|
| Volatility | 93.9% |
| Relative Tail Risk | -11.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.26 |
| Alpha | 52.90 |
| Character TTM | |
|---|---|
| Beta | 1.384 |
| Beta Downside | 3.317 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.87% |
| CAGR/Max DD | 0.17 |
EPS (Earnings per Share)
Revenue
Description: CLMT Calumet Specialty Products February 24, 2026
Calumet Specialty Products Partners (CLMT) manufactures and markets a broad portfolio of specialty chemicals, renewable fuels, and performance brands. Its operations are organized into three segments: Specialty Products & Solutions (solvents, waxes, lubricants, etc.), Montana/Renewables (renewable diesel, SAF, renewable hydrogen, plus conventional fuels from Canadian crude), and Performance Brands (Royal Purple, Bel-Ray, TruFuel). The company serves both industrial and consumer-facing customers across North America and select international markets.
In the most recent quarter (Q4 2025), Calumet reported net sales of $1.18 billion, a 7% year-over-year increase, driven largely by a 15% rise in renewable fuel volumes. Adjusted EBITDA margin expanded to 9.2%, up from 7.8% a year earlier, reflecting higher margins on renewable diesel and sustainable aviation fuel (SAF) production. The Performance Brands segment contributed $210 million in revenue, with Royal Purple maintaining a 12% market-share lead in high-performance lubricants.
Key economic drivers include the U.S. Renewable Fuel Standard (RFS) credit prices, which have risen 22% since the start of 2024, and the Federal Aviation Administration’s mandate targeting 10% SAF use in commercial jet fuel by 2030. Additionally, tightening crude oil supply constraints in the Midwest have boosted demand for Calumet’s domestic gasoline and diesel processing capacity, supporting price spreads for its Montana/Renewables output.
For a deeper dive into CLMT’s valuation and outlook, consider reviewing the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income: error (cannot be calculated; needs Net Income TTM and Revenue TTM) |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA -3.92 > 1.0 |
| NWC/Revenue: error (cannot be calculated; needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA -0.00 > 3% & CFO -11.0m > Net Income -69.0m |
| Net Debt (2.30b) to EBITDA (253.0m): 9.10 < 3 |
| Current Ratio: 1.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (86.7m) vs 12m ago 0.72% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 0.0% > 50% (prev 156.5%; Δ -156.5% > 0%) |
| Interest Coverage Ratio: 0.26 > 6 (EBITDA TTM 253.0m / Interest Expense TTM 216.0m) |
Altman Z'' -1.44
| A: 0.04 (Total Current Assets 880.1m - Total Current Liabilities 776.3m) / Total Assets 2.73b |
| B: -0.56 (Retained Earnings -1.54b / Total Assets 2.73b) |
| C: 0.02 (EBIT TTM 57.0m / Avg Total Assets 2.75b) |
| D: 0.0 (Book Value of Equity 0.0 / Total Liabilities 3.18b) |
| Altman-Z'' Score: -1.44 = CCC |
Beneish M
| DSRI: none (Receivables none/278.1m, Revenue 0.0/4.32b) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: none (Revenue 0.0 / 4.32b) |
| TATA: -0.02 (NI -69.0m - CFO -11.0m) / TA 2.73b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of CLMT shares?
Over the past week, the price has changed by -7.03%, over one month by +18.61%, over three months by +39.47% and over the past year by +100.30%.
Is CLMT a buy, sell or hold?
- StrongBuy: 2
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CLMT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27 | 0.1% |
| Analysts Target Price | 27 | 0.1% |
CLMT Fundamental Data Overview February 27, 2026
P/S = 0.6342
P/B = 19.3228
P/EG = 2.71
Revenue TTM = 0.0 USD
EBIT TTM = 57.0m USD
EBITDA TTM = 253.0m USD
Long Term Debt = 2.15b USD (from longTermDebt, two quarters ago)
Short Term Debt = 155.2m USD (from shortTermDebt, two quarters ago)
Debt = 2.30b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 2.30b USD (using Total Debt 2.30b, CCE unavailable)
Enterprise Value = 4.87b USD (2.57b + Debt 2.30b - (null CCE))
Interest Coverage Ratio = 0.26 (Ebit TTM 57.0m / Interest Expense TTM 216.0m)
EV/FCF = -64.41x (Enterprise Value 4.87b / FCF TTM -75.6m)
FCF Yield = -1.55% (FCF TTM -75.6m / Enterprise Value 4.87b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 1.78 (Enterprise Value 4.87b / Total Assets 2.73b)
Interest Expense / Debt = 2.21% (Interest Expense 51.0m / Debt 2.30b)
Taxrate = 21.0% (US default 21%)
NOPAT = 45.0m (EBIT 57.0m * (1 - 21.00%))
Current Ratio = 1.13 (Total Current Assets 880.1m / Total Current Liabilities 776.3m)
Debt / Equity = -3.31 (negative equity) (Debt 2.30b / totalStockholderEquity, two quarters ago -695.3m)
Debt / EBITDA = 9.10 (Net Debt 2.30b / EBITDA 253.0m)
Debt / FCF = -30.46 (negative FCF - burning cash) (Net Debt 2.30b / FCF TTM -75.6m)
Total Stockholder Equity = -820.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.51% (Net Income -69.0m / Total Assets 2.73b)
RoE = 8.41% (negative equity) (Net Income TTM -69.0m / Total Stockholder Equity -820.0m)
RoCE = 4.29% (EBIT 57.0m / Capital Employed (Equity -820.0m + L.T.Debt 2.15b))
RoIC = 3.07% (NOPAT 45.0m / Invested Capital 1.47b)
WACC = 6.64% (E(2.57b)/V(4.87b) * Re(11.02%) + D(2.30b)/V(4.87b) * Rd(2.21%) * (1-Tc(0.21)))
Discount Rate = 11.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.00%
[DCF] Fair Price = unknown (Cash Flow -75.6m)
EPS Correlation: 7.76 | EPS CAGR: 28.81% | SUE: 0.13 | # QB: 0
Revenue Correlation: -42.92 | Revenue CAGR: -62.50% | SUE: 0.40 | # QB: 0
EPS next Year (2026-12-31): EPS=-0.71 | Chg7d=+0.258 | Chg30d=+0.775 | Revisions Net=-1 | Growth EPS=-76.5% | Growth Revenue=+2.5%